Publicaties
2025
Wetenschappelijke publicaties
Leung, M. W. Y., van de Garde, E. M. W., Uitdehaag, B. M. J., Souverein, P. C., Klungel, O. H., & Bazelier, M. T. (2025). The Effect of Use of Tricyclic Antidepressants or Serotonin-Norepinephrine Reuptake Inhibitors Versus Selective Serotonin Reuptake Inhibitors on the Risk of Urinary Tract Infection Among People With Multiple Sclerosis: A Nested Case–Control Study. Pharmacoepidemiology and Drug Safety, 34(11), Article e70260. [DOI] [Portal]
Verschueren, M. V., Verschueren, D. V., van de Garde, E. M. W., & Bloem, L. T. (2025). A Bayesian Approach to Compare Accumulating Survival Data From Clinical Practice With RCT Data: A Case Study in Non-Small Cell Lung Cancer Patients. CPT: Pharmacometrics and Systems Pharmacology. Advance online publication. [DOI]
Kalkhoran, H. A., Verschueren, M. V., Peters, B. J. M., van de Garde, E. M. W., Smit, E. F., Bohringer, S., Cohen, D., Gulikers, J. L., Codrington, H., Guchelaar, H.-J., Visser, L. E., & Zwaveling, J. (2025). Real World Effectiveness of Durvalumab in Stage III Unresectable Non-small Cell Lung Cancer: What is the Role of PD-L1 Expression? Clinical Lung Cancer, 26(7), e599-e608.e2. [DOI] [Portal]
Reesink, D. J., Voskuilen, C. S., van de Garde, E. M. W., Hendricksen, K., Horenblas, S., van Melick, H. H. E., & van Rhijn, B. W. G. (2025). Survival in Responders and Nonresponders of Neoadjuvant and Induction Chemotherapy in Invasive Urothelial Carcinoma of the Urinary Bladder: A Clinical and Pathological Stage-Matched Analysis. Clinical Genitourinary Cancer, 23(3), Article 102319. [DOI] [Portal]
Miguel, J. W. A. M., van Veen, N. L., Jacobs, W., Damhuis, R. A. M., van Uden-Kraan, C. F., & van de Garde, E. M. W. (2025). Applied first-line systemic treatments, treatment modifications and outcomes in non-oncogenic metastatic non-small cell lung cancer in the Netherlands in 2019–2020: A nationwide study. Cancer Epidemiology, 96, Article 102809. [DOI] [Portal]
Smit, J. M., Van Der Zee, P. A., Stoof, S. C. M., Van Genderen, M. E., Snijders, D., Boersma, W. G., Confalonieri, P., Salton, F., Confalonieri, M., Shih, M.-C., Meduri, G. U., Dequin, P.-F., Le Gouge, A., Lloyd, M., Karunajeewa, H., Bartminski, G., Fernández-Serrano, S., Suárez-Cuartín, G., van Klaveren, D., ... Endeman, H. (2025). Predicting benefit from adjuvant therapy with corticosteroids in community-acquired pneumonia: a data-driven analysis of randomised trials. The Lancet Respiratory Medicine, 13(3), 221-233. [DOI] [Portal]
Verschueren, M. V., Tassopoulou, V. P., Visscher, R., Schuurkamp, J., Peters, B. J. M., Koopman, M., van de Garde, E. M. W., Egberts, A. C. G., & Bloem, L. T. (2025). Definitions, measurement, and reporting of progression-free survival in randomized clinical trials and observational studies of patients with advanced non-small-cell lung cancer treated with immunotherapy: a scoping review. ESMO Real World Data and Digital Oncology, 7, Article 100118. [DOI] [Portal]
Verschueren, M. V., Hiensch, D. T. A., Plomp, P. M. J., Kastelijn, L. A., van de Garde, E. M. W., & Peters, B. J. M. (2025). Comparative Effectiveness of Nivolumab and Ipilimumab Plus Chemotherapy Versus Pembrolizumab Plus Chemotherapy in PD-L1 Negative Metastatic Non-Small Cell Lung Cancer Patients. Clinical Lung Cancer, 26(4), e243-e248.e1. [DOI] [Portal]
Leung, M. W. Y., Garde, E. M. W. V. D., Uitdehaag, B. M. J., Klungel, O. H., & Bazelier, M. T. (2025). The relative risk of infection in people with multiple sclerosis using disease-modifying treatment: a systematic review of observational studies. Neurological Sciences, 46(6), 2555-2569. [DOI] [Portal]
Dutch CDSS‐efficiency study group, Graafsma, J., van de Garde, E. M. W., Derijks, H. J., Hoge, R. H. L., Klopotowska, J. E., Karapinar-Carkit, F., & van den Bemt, P. M. L. A. (2025). Efficiency of computerized clinical decision support systems involving anticoagulants: A flashmob study in Dutch hospital pharmacies. British Journal of Clinical Pharmacology, 91(1), 157-165. [DOI] [Portal]
2024
Wetenschappelijke publicaties
Verschueren, M. V., Abedian Kalkhoran, H., Deenen, M., van den Borne, B. E. E. M., Zwaveling, J., Visser, L. E., Bloem, L. T., Peters, B. J. M., & van de Garde, E. M. W. (2024). Development and Portability of a Text Mining Algorithm for Capturing Disease Progression in Electronic Health Records of Patients With Stage IV Non-Small Cell Lung Cancer. JCO clinical cancer informatics, 8, Article e2400053. [DOI] [Portal]
Graafsma, J., Murphy, R. M., Van De Garde, E. M. W., Karapinar-Çarkit, F., Derijks, H. J., Hoge, R. H. L., Klopotowska, J. E., & Van Den Bemt, P. M. L. A. (2024). The use of artificial intelligence to optimize medication alerts generated by clinical decision support systems: a scoping review. Journal of the American Medical Informatics Association, 31(6), 1411-1422. [DOI] [Portal]
van Nuland, M., Lobbezoo, A.-F. H., van de Garde, E. M. W., Herbrink, M., van Heijl, I., Bognàr, T., Houwen, J. P. A., Dekens, M., Wannet, D., Egberts, T., & van der Linden, P. D. (2024). Assessing accuracy of ChatGPT in response to questions from day to day pharmaceutical care in hospitals. Exploratory Research in Clinical and Social Pharmacy, 15, Article 100464. [DOI] [Portal]
den Hartog, I., Zwep, LB., Meulman, JJ., Hankemeier, T., van de Garde, EMW., & van Hasselt, JGC. (2024). Longitudinal metabolite profiling of <i>Streptococcus pneumoniae</i>-associated community-acquired pneumonia. Metabolomics, 20(2), Article 35. [DOI] [Repository]
Verschueren, M. V., Peters, B. J., Bloem, L. T., Kruik, V. R., Uitvlugt, E. B., Bijsmans, A. R., Egberts, A. C., & van de Garde, E. M. (2024). Pembrolizumab Plus Chemotherapy Per PD-L1 Stratum In Patients With Metastatic Non-Small Cell Lung Cancer: Real-World Effectiveness Versus Trial Efficacy. Clinical Lung Cancer, 25(2), 119-127.e1. [DOI] [Repository]
van Veelen, A., Veerman, G. D. M., Verschueren, M. V., Gulikers, J. L., Steendam, C. M. J., Brouns, A. J. W. M., Dursun, S., Paats, M. S., Tjan-Heijnen, V. C. G., van der Leest, C., Dingemans, A. M. C., Mathijssen, R. H. J., van de Garde, E. M. W., Souverein, P., Driessen, J. H. M., Hendriks, L. E. L., van Geel, R. M. J. M., & Croes, S. (2024). Exploring the impact of patient-specific clinical features on osimertinib effectiveness in a real-world cohort of patients with EGFR mutated non-small cell lung cancer. International Journal of Cancer, 154(2), 332-342. [DOI] [Repository]
Vakpublicaties
Santeon MIBC-studiegroep, Reesink, D. J., van de Garde, E. M. W., van der Nat, P. B., Los, M., Horenblas, S., & van Melick, H. H. E. (2024). Uitkomsten in de dagelijkse praktijk van eerstelijnschemotherapie voor niet-resectabel stadium III en IV urotheelcarcinoom van de blaas. Tijdschrift voor Urologie, 14(4), 74-84. [DOI] [Portal]
2023
Wetenschappelijke publicaties
Chahid, Y., Chahid, F., van de Garde, E., Booij, J., Verberne, H. J., & Hendrikse, N. H. (2023). CYP3A4 inhibitors do not influence [68Ga]Ga-DOTA-TATE uptake in liver tissue. EJNMMI Research, 13(1), Article 84. [DOI] [Repository]
Chahid, Y., Hashimi, K., van de Garde, E. M. W., Klümpen, H.-J., Hendrikse, N. H., Booij, J., & Verberne, H. J. (2023). The Influence of Long-Acting Somatostatin Analogs on 68 Ga-DOTATATE Uptake in Patients With Neuroendocrine Tumors. Clinical Nuclear Medicine, 48(9), 757-762. [DOI] [Repository]
Verschueren, M. V., Dijs, T., Gulikers, J. L., Veelen, A. V., Croes, S., Hendriks, L. E., Smit, A. A., Bloem, L. T., Egberts, A. C., van de Garde, E. M., & Peters, B. J. (2023). Durvalumab after chemoradiotherapy in patients with stage III non-small-cell lung cancer: real-world outcomes versus clinical trial results. Immunotherapy, 15(11), 839-851. [DOI] [Repository]
den Hartog, I., Karu, N., Zwep, L. B., Voorn, G. P., van de Garde, E. M. W., Hankemeier, T., & van Hasselt, J. G. C. (2023). Differential metabolic host response to pathogens associated with community-acquired pneumonia. Metabolism open, 18, Article 100239. [DOI] [Repository]
Santeon MIBC Study Group (2023). Real-world outcomes of first-line chemotherapy for unresectable stage III and IV bladder cancer. World Journal of Urology, 41(6), 1551–1562. [DOI] [Repository]
Vis, R., Mathijssen, H., Keijsers, R. G. M., van de Garde, E. M. W., Veltkamp, M., Akdim, F., Post, M. C., & Grutters, J. C. (2023). Prednisone vs methotrexate in treatment naïve cardiac sarcoidosis. Journal of Nuclear Cardiology, 30(4), 1543-1553. [DOI] [Repository]
Ismail, R. K., Schramel, F. M. N. H., van Dartel, M., Pasmooij, A. M. G., der Welle, C. M. C., Hilarius, D. L., de Boer, A., Wouters, M. W. J. M., & van de Garde, E. M. W. (2023). Correction: Individual patient data to allow a more elaborated comparison of trial results with real-world outcomes from second-line immunotherapy in NSCLC (BMC Medical Research Methodology, (2023), 23, 1, (1), 10.1186/s12874-022-01760-0). BMC Medical Research Methodology, 23(1), Article 26. [DOI] [Repository]
Mfumbilwa, Z. A., Wilschut, J. A., Simons, M. J. H. G., Ramaekers, B., Joore, M., Retèl, V., der Welle, C. M. C., Schramel, F. M. N. H., van de Garde, E. M. W., & Coupé, V. M. H. (2023). Development and validation of a decision model for the evaluation of novel lung cancer treatments in the Netherlands. Scientific Reports, 13(1), Article 2349. [DOI] [Repository]
Adams, H., van de Garde, E. M. W., Vugts, D. J., Grutters, J. C., Oyen, W. J. G., & Keijsers, R. G. (2023). [89Zr]-immuno-PET prediction of response to rituximab treatment in patients with therapy refractory interstitial pneumonitis: a phase 2 trial. European Journal of Nuclear Medicine and Molecular Imaging, 50(7), 1929-1939. [DOI] [Repository]
Wittermans, E., van der Zee, P. A., Qi, H., Grutters, J. C., Voorn, G. P., Bos, W. J. W., van de Garde, E. M. W., & Endeman, H. (2023). Latent class analysis-based subgroups and response to corticosteroids in hospitalised community-acquired pneumonia patients: a validation study. ERJ Open Research, 9(2), Article 00577-2022. [DOI] [Repository]
Hackert, M. Q. N., van Uden-Kraan, C. F., Agterof, M. J., van der Velden, A. W. G., Vriens, B. E. P. J., Janssen, J. J. B., Geenen, M., van der Padt-Pruijsten, A., & van de Garde, E. M. W. (2023). Real-world palbociclib effectiveness in patients with metastatic breast cancer: Focus on neutropenia-related treatment modification strategies and clinical outcomes. Cancer Treatment and Research Communications, 35, Article 100691. [DOI] [Repository]
Ismail, R. K., Schramel, F. M. N. H., van Dartel, M., Pasmooij, A. M. G., Cramer-van der Welle, C. M., Hilarius, D. L., de Boer, A., Wouters, M. W. J. M., & van de Garde, E. M. W. (2023). Individual patient data to allow a more elaborated comparison of trial results with real-world outcomes from first-line immunotherapy in NSCLC. BMC Medical Research Methodology, 23(1), Article 1. [DOI] [Repository]
Overige resultaten
Verschueren, M., Kruik, V., Peters, B., Bloem, L., Bijsmans, A. R., Egberts, T., & van de Garde, E. (2023). Real-world versus clinical trial outcomes of pembrolizumab plus chemotherapy in patients with stage IV non-squamous non-small cell lung cancer. Journal of Thoracic Oncology, 18(4), S72-S72.
2022
Wetenschappelijke publicaties
(S.O.S.MS Consensus Group) (2022). Development of an international, multidisciplinary, patient-centered Standard Outcome Set for Multiple Sclerosis: The S.O.S.MS project. Multiple Sclerosis and Related Disorders, 69, 1-7. Article 104461. [DOI] [Repository]
Santeon NSCLC Study Group (2022). The association of body mass index with safety and effectiveness of first-line carboplatin-based chemotherapy in patients with metastatic non-small cell lung cancer. Cancer Treatment and Research Communications, 34, 1-9. Article 100676. [DOI] [Repository]
Wittermans, E., Grutters, J. C., Moeniralam, H. S., Ocak, G., Paul Voorn, G., Bos, W. J. W., & van de Garde, E. M. W. (2022). Overweight and obesity are not associated with worse clinical outcomes in COVID-19 patients treated with fixed-dose 6 mg dexamethasone. International Journal of Obesity, 46(11), 2000-2005. [DOI] [Repository]
Al Khayat, M. N. M. T., Eijsink, J. F. H., Postma, M. J., van de Garde, E. M. W., & van Hulst, M. (2022). Cost-effectiveness of screening smokers and ex-smokers for lung cancer in the Netherlands in different age groups. European Journal of Health Economics, 23(7), 1221-1227. [DOI] [Repository]
Wittermans, E., van der Zee, P. A., Qi, H., van de Garde, E. M. W., Blum, C. A., Christ-Crain, M., Gommers, D., Grutters, J. C., Voorn, G. P., Bos, W. J. W., & Endeman, H. (2022). Community-acquired pneumonia subgroups and differential response to corticosteroids: a secondary analysis of controlled studies. ERJ Open Research, 8(1), 1-11. Article 00489-2021. [DOI] [Repository]
TRACE Study investigators (2022). Validation of the PreOperative Score to predict Post-Operative Mortality (POSPOM) in Dutch non-cardiac surgery patients. BMC Anesthesiology, 22(1), 58. Article 58. [DOI] [Repository]
Santeon MIBC Study Group (2022). Hospital variation in treatment patterns and oncological outcomes for patients with muscle-invasive and metastatic bladder cancer in the Netherlands. World Journal of Urology, 40(6), 1469–1479. [DOI] [Repository]
Santeon-CAP study group (2022). Neutrophil count, lymphocyte count and neutrophil-to-lymphocyte ratio in relation to response to adjunctive dexamethasone treatment in community-acquired pneumonia. European Journal of Internal Medicine, 96, 102-108. [DOI] [Repository]
Uitvlugt, E. B., Soeng, D. Y. F., van der Linden, P., & van de Garde, E. M. W. (2022). The dynamics in applied COVID-19 pharmacotherapy and the influence of national guidance in The Netherlands: a quantitative and qualitative study. European Journal of Hospital Pharmacy, 29, e83–e86. [DOI] [Repository]
2021
Wetenschappelijke publicaties
Chahid, Y., Qiu, X., van de Garde, E. M. W., Verberne, H. J., & Booij, J. (2021). Risk factors for nonvisualization of the sentinel lymph node on lymphoscintigraphy in breast cancer patients. EJNMMI Research, 11(1), 1-6. Article 54. [DOI] [Repository]
Den Hartog, I., Zwep, L. B., Vestjens, S. M. T., Harms, A. C., Voorn, G. P., De Lange, D. W., Bos, W. J. W., Hankemeier, T., Van De Garde, E. M. W., & Van Hassel, J. G. C. (2021). Metabolomic profiling of microbial disease etiology in community-acquired pneumonia. PLoS One, 16(6), 1-15. Article e0252378. [DOI] [Repository]
Cramer-Van der Welle, C. M., Kastelijn, E. A., Plouvie, B. C., Van Uden-Kraan, C. F., Schramel, F. M. N. H., Groen, H. J. M., & Van de Garde, E. M. W. (2021). Development and evaluation of a real-world outcomes-based tool to support informed clinical decision making in the palliative treatment of patients with metastatic nsclc. JCO clinical cancer informatics, 5, 570-578. [DOI] [Repository]
Verschueren, M. V., van der Welle, C. M. C., Tonn, M., Schramel, F. M. N. H., Peters, B. J. M., & van de Garde, E. M. W. (2021). The association between gut microbiome affecting concomitant medication and the effectiveness of immunotherapy in patients with stage IV NSCLC. Scientific Reports, 11(1), 1-8. Article 23331. [DOI] [Repository]
de Vries Schultink, A. H. M., Sallevelt, B. T. G. M., Meinders, A. J., van de Garde, E. M. W., & Roescher, N. (2021). The need for gentamicin adjunctive to cefuroxime as empirical sepsis therapy: a local protocol evaluation. Clinical Microbiology and Infection, 27(9), 1354-1355. [DOI] [Repository]
for the Santeon MIBC Study Group (2021). Development of the First Patient-centred Set of Outcomes for Muscle-invasive and Metastatic Bladder Cancer: A Multicentre Initiative. European Urology Open Science, 26, 18-26. [DOI] [Repository]
The Santeon NSCLC Study Group (2021). Real-world outcomes versus clinical trial results of immunotherapy in stage IV non-small cell lung cancer (NSCLC) in the Netherlands. Scientific Reports, 11(1), Article 6306. [DOI] [Repository]
van der Sande, L. J. T. M., Jöbsis, Q., Bannier, M. A. G. E., van de Garde, E. M. W., Coremans, J. J. M., de Vries, F., Dompeling, E., & Driessen, J. H. M. (2021). The risk of community-acquired pneumonia in children using gastric acid suppressants. European Journal of Respiratory Diseases, 58(4), 1-9. Article 2003229. [DOI] [Repository]
Cramer-van der Welle, C. M., Peters, B. J. M., Deenen, M. J., Schramel, F. M. N. H., & van de Garde, E. M. W. (2021). Trends in Drug Costs and Overall Survival in Patients with Metastatic Non-small Cell Lung Cancer in The Netherlands Diagnosed from 2008 Through 2014. PharmacoEconomics - Open, 5, 121–127. [DOI] [Repository]
Marin-Corral, J., Pascual-Guardia, S., Amati, F., Aliberti, S., Masclans, J. R., Soni, N., Rodriguez, A., Sibila, O., Sanz, F., Sotgiu, G., Anzueto, A., Dimakou, K., Petrino, R., van de Garde, E., & Restrepo, M. I. (2021). Aspiration Risk Factors, Microbiology, and Empiric Antibiotics for Patients Hospitalized With Community-Acquired Pneumonia. Chest, 159(1), 58-72. [DOI] [Repository]
Sieswerda, E., de Boer, M. G. J., Bonten, M. M. J., Boersma, W. G., Jonkers, R. E., Aleva, R. M., Kullberg, B.-J., Schouten, J. A., van de Garde, E. M. W., Verheij, T. J., van der Eerden, M. M., Prins, J. M., & Wiersinga, W. J. (2021). Recommendations for antibacterial therapy in adults with COVID-19 - an evidence based guideline. Clinical Microbiology and Infection, 27(1), 61-66. [DOI] [Repository]
Wittermans, E., Vestjens, S. M., Spoorenberg, S. M., Blok, W. L., Grutters, J. C., Janssen, R., Rijkers, G. T., Smeenk, F. W., Voorn, P., van de Garde, E. M., & Bos, W. J. W. (2021). Adjunctive treatment with oral dexamethasone in non-ICU patients hospitalised with community-acquired pneumonia: A randomised clinical trial. European Clinical Respiratory Journal, 58(2), 1-10. Article 2002535. [DOI] [Repository]
Cramer-van der Welle, C. M., Schramel, F. M. N. H., Peters, B. J. M., van Putten, J. W. G., Klungel, O. H., Groen, H. J. M., & van de Garde, E. M. W. (2021). Systematic evaluation of the efficacy-effectiveness gap of systemic treatments in extensive disease small cell lung cancer. Pharmacoepidemiology and Drug Safety, 30(4), 445-450. [DOI] [Repository]
2020
Wetenschappelijke publicaties
Reesink, D. J., van de Garde, E. M. W., Peters, B. J. M., van der Nat, P. B., Los, M., Horenblas, S., & van Melick, H. H. E. (2020). Treatment patterns and clinical outcomes of chemotherapy treatment in patients with muscle-invasive or metastatic bladder cancer in the Netherlands. Scientific Reports, 10(1), Article 15822. [DOI] [Repository]
Adams, H., Meek, B., van de Garde, E. M., van Moorsel, C. H., Vugts, D. J., Keijsers, R. G., & Grutters, J. C. (2020). Altered splenic [89Zr]Zr-rituximab uptake in patients with interstitial lung disease not responding to rituximab: could this indicate a splenic immune-mediated mechanism? American Journal of Nuclear Medicine and Molecular Imaging, 10(4), 168-177. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7486548/ [Repository]
Daniels, K., van der Nat, P. B., Frequin, S. T. F. M., van der Wees, P. J., Biesma, D. H., Hoogervorst, E. L. J., & van de Garde, E. M. W. (2020). Real-World Results of Ocrelizumab Treatment for Primary Progressive Multiple Sclerosis. Multiple Sclerosis International, 2020, Article 5463451. [DOI] [Repository]
van de Garde, E. M. W., van Bedaf, L. R., Hurkmans, D. P., & van den Heuvel, M. M. (2020). Antibiotic use and reduced effectiveness of second-line immunotherapy for lung cancer: all the time or just at the start of treatment? Annals of Oncology, 31(12), 1779-1780. [DOI] [Repository]
Vis, R., van de Garde, E. M. W., Meek, B., Korenromp, I. H. E., & Grutters, J. C. (2020). Randomised, placebo-controlled trial of dexamethasone for quality of life in pulmonary sarcoidosis. Respiratory Medicine, 165, Article 105936. [DOI] [Repository]
van den Broek, M. P. H., Möhlmann, J. E., Abeln, B. G. S., Liebregts, M., van Dijk, V. F., & van de Garde, E. M. W. (2020). Chloroquine-induced QTc prolongation in COVID-19 patients. Netherlands Heart Journal, 28(7-8), 406-409. [DOI] [Repository]
Cramer-van der Welle, C. M., Schramel, F. M. N. H., van Leeuwen, A. S., Groen, H. J. M., & van de Garde, E. M. W. (2020). Real-world treatment patterns and outcomes of patients with extensive disease small cell lung cancer. European Journal of Cancer Care, 29(5), 1-6. Article e13250. [DOI] [Repository]
Vis, R., van de Garde, E. M. W., Grutters, J. C., & Korenromp, I. H. E. (2020). The effects of pharmacological interventions on quality of life and fatigue in sarcoidosis: a systematic review. European Respiratory Review, 29(155), Article 190057. [DOI] [Repository]
Zhang, Z. X., van de Garde, E. M. W., Söhne, M., Harmsze, A. M., & van den Broek, M. P. H. (2020). Quality of clinical Direct Oral Anticoagulants (DOACs) prescribing and identification of risk factors for inappropriate prescriptions. British Journal of Clinical Pharmacology, 86(8), 1567-1574. [DOI] [Repository]
Révész, D., Engelhardt, E. G., Tamminga, J. J., Schramel, F. M. N. H., Onwuteaka-Philipsen, B. D., van de Garde, E. M. W., Steyerberg, E. W., de Vet, H. C. W., & Coupé, V. M. H. (2020). Needs with Regard to Decision Support Systems for Treating Patients with Incurable Non-small Cell Lung Cancer. Journal of Cancer Education, 35(2), 345-351. [DOI] [Repository]
2019
Wetenschappelijke publicaties
Adams, H., van de Garde, E. M., van Moorsel, C. H., Vugts, D. J., van Dongen, G. A., Grutters, J. C., & Keijsers, R. G. (2019). [89Zr]Zr-rituximab PET/CT activity in patients with therapy refractory interstitial pneumonitis: a feasibility study. American Journal of Nuclear Medicine and Molecular Imaging, 9(6), 296-308. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6971479/ [Repository]
Kaldeway, H. P., Ter Borg, E. J., Van De Garde, E. M. W., Habraken, J. B. A., & Van Buul, M. M. C. (2019). Validation of quantitative salivary gland scintigraphy in relation to the American-European concensus criteria for Sjögren's syndrome. Nuclear Medicine Communications, 40(4), 343-348. [DOI] [Repository]
Bury, D., Ter Heine, R., van de Garde, E. M. W., Nijziel, M. R., Grouls, R. J., & Deenen, M. J. (2019). The effect of neutropenia on the clinical pharmacokinetics of vancomycin in adults. European Journal of Clinical Pharmacology, 75, 921–928. [DOI] [Repository]
Wittermans, E., Vestjens, S. M. T., Bos, W. J. W., Grutters, J. C., van de Garde, E. M. W., & Vlaminckx, B. J. M. (2019). The extent of microbiological testing is associated with alteration of antibiotic therapy in adults with community-acquired pneumonia. European Journal of Clinical Microbiology and Infectious Diseases, 38, 1359–1366. [DOI] [Repository]
Vlot, E. A., Verwijmeren, L., van de Garde, E. M. W., Kloppenburg, G. T. L., van Dongen, E. P. A., & Noordzij, P. G. (2019). Intra-operative red blood cell transfusion and mortality after cardiac surgery. Anesthesiology, 19(1), Article 65. [DOI] [Repository]
Bui, T. B. V., Burgers, D. M., Agterof, M. J., & van de Garde, E. M. (2019). Real-World Effectiveness of Palbociclib Versus Clinical Trial Results in Patients With Advanced/Metastatic Breast Cancer That Progressed on Previous Endocrine Therapy. Breast cancer : basic and clinical research, 13, 1-6. [DOI] [Repository]
SWAB’s Working Group on Surveillance of Antimicrobial Use (2019). Consecutive antibiotic use in the outpatient setting: an extensive, longitudinal descriptive analysis of antibiotic dispensing data in the Netherlands. BMC Infectious Diseases, 19(1), Article 84. [DOI] [Repository]
GLIMP Study Group (2019). An international perspective on hospitalized patients with viral community-acquired pneumonia. European Journal of Internal Medicine, 60, 54-70. [DOI] [Repository]
Saleh, M. A. A., van de Garde, E. M. W., & van Hasselt, J. G. C. (2019). Host-response biomarkers for the diagnosis of bacterial respiratory tract infections. Clinical Chemistry and Laboratory Medicine, 57(4), 442-451. [DOI] [Repository]
Van De Garde, E. M. W., Plouvier, B. C., Fleuren, H. W. H. A., Haak, E. A. F., Movig, K. L. L., Deenen, M. J., & Van Hulst, M. (2019). Pharmacotherapy within a learning healthcare system: Rationale for the Dutch Santeon Farmadatabase. European Journal of Hospital Pharmacy, 26, 46-50. [DOI] [Repository]
2018
Wetenschappelijke publicaties
Vestjens, S. M. T., Wittermans, E., Spoorenberg, S. M. C., Grutters, J. C., van Ruitenbeek, C. A., Voorn, G. P., Bos, W. J. W., & van de Garde, E. M. W. (2018). Inter-hospital variation in the utilization of diagnostics and their proportionality in the management of adult community-acquired pneumonia. Pneumonia, 10(15), Article 15. [DOI] [Repository]
Santeon NSCLC Study Group (2018). Systematic evaluation of the efficacy-effectiveness gap of systemic treatments in metastatic nonsmall cell lung cancer. European Respiratory Journal, 52(6), Article 1801100. [DOI] [Repository]
Smit, C. H., Wiertz-Arts, K., & van de Garde, E. M. (2018). Intravitreal aflibercept versus intravitreal ranibizumab in patients with age-related macular degeneration: a comparative effectiveness study. Comparative Hepatology, 7(6), 561-567. [DOI] [Repository]
Lentferink, Y. E., van de Garde, E. M. W., Knibbe, C. A. J., & van der Vorst, M. M. J. (2018). Psychostimulants: Influence on Body Mass Index and Height in a Pediatric Population with Attention-Deficit/Hyperactivity Disorder? Journal of Child and Adolescent Psychopharmacology, 28(8), 530–536. [DOI] [Repository]
Rottier, W. C., van Werkhoven, C. H., Bamberg, Y. R. P., Dorigo-Zetsma, J. W., van de Garde, E. M., van Hees, B. C., Kluytmans, J. A. J. W., Kuck, E. M., Van Der Linden, P. D., Prins, J. M., Thijsen, S. F. T., Verbon, A., Vlaminckx, B. J. M., Ammerlaan, H. S. M., & Bonten, M. J. M. (2018). Development of diagnostic prediction tools for bacteraemia caused by 3rd generation cephalosporin-resistant Enterobacteriaceae in suspected bacterial infections: a nested case-control study. Clinical Microbiology and Infection, 24(12), 1315–1321. [DOI] [Repository]
Wiersinga, W. J., Bonten, M. J. M., Boersma, W. G., Jonkers, R. E., Aleva, R. M., Kullberg, B.-J., Schouten, J. A., Degener, J. E., van de Garde, E. M. W., Verheij, T., Sachs, A. P. E., & Prins, J. M. (2018). Management of community-acquired pneumonia in adults: 2016 guideline update from the Dutch Working Party on Antibiotic Policy (SWAB) and Dutch Association of Chest Physicians (NVALT). Netherlands Journal of Medicine, 76(1), 4-13. https://www.ncbi.nlm.nih.gov/pubmed/29380739 [Repository]
Rettig, T. C. D., Nijenhuis, V. J., Meek, B., Rigter, S., Ten Berg, J. M., Vlaminckx, B. J. M., van Klei, W. A., van de Garde, E. M. W., Peelen, L. M., & Noordzij, P. G. (2018). Systemic Inflammation after Transcatheter Aortic Valve Implantation: A Prospective Exploratory Study. Journal of Cardiothoracic and Vascular Anesthesia, 32(4), e77-e82. [DOI] [Repository]
de Hoogd, S., Ahlers, S. J. G. M., van Dongen, E. P. A., van de Garde, E. M. W., Daeter, E. J., Dahan, A., Tibboel, D., & Knibbe, C. A. J. (2018). Randomized Controlled Trial on the Influence of Intraoperative Remifentanil versus Fentanyl on Acute and Chronic Pain after Cardiac Surgery. Pain Practice, 18(4), 443-451. [DOI] [Repository]
Vestjens, S. M. T., Spoorenberg, S. M. C., van de Garde, E. M. W., & Bos, W. J. W. (2018). Inclusion of sepsis and hypoxaemia in mortality prediction of hospitalized patients with community-acquired pneumonia - Reply. Respirology, 23(1), 114-115. [DOI] [Repository]
Rettig, T. C. D., Verwijmeren, L., van de Garde, E. M. W., & Noordzij, P. G. (2018). Letter in Response to “No Cytokine is an Island: IL-6 Alone is not Enough to Predict the Morbidity After Major Abdominal Surgery”. Annals of Surgery, 267(2), e32–e33. [DOI] [Repository]
2017
Wetenschappelijke publicaties
Peters, B. J. M., Cramer-Vd Welle, C. M., Smit, A. A. J., Schramel, F. M. N. H., van de Garde, E. M. W., & Santeon NSCLC Study Group (2017). Trends in prescribing systemic treatment and overall survival for non-small cell lung cancer stage IIIB/IV in the Netherlands: 2008-2012. Cancer Epidemiology, 51, 1-6. [DOI] [Repository]
Révész, D., Engelhardt, E. G., Tamminga, J. J., Schramel, F. M. N. H., Onwuteaka-Philipsen, B. D., van de Garde, E. M. W., Steyerberg, E. W., Jansma, E. P., de Vet, H. C. W., & Coupé, V. M. H. (2017). Decision support systems for incurable non-small cell lung cancer: a systematic review. BMC Medical Informatics and Decision Making, 17(1), Article 144. [DOI] [Repository]
van de Garde, E. M. W., van Wessel, T., Teeuwisse, A. K., & Steenman, S. C. (2017). Selectie of 'gewongen matching' in de master: Identificeren van instrumenten die studiesucces kunnen voorspellen bij Farmacie. Onderzoek van Onderwijs, 46(2), 8-12. https://www.tijdschriftovo.nl/art/50-4615_Selectie-of-gedwongen-matching-in-de-master-identificeren-van-instrumenten-die-studiesucces-kunnen-voorspellen-bij-Farmacie [Repository]
Spoorenberg, S. M. C., Vestjens, S. M. T., Rijkers, G. T., Meek, B., van Moorsel, C. H. M., Grutters, J. C., Bos, W. J. W., Biesma, D. H., Endeman, H., van de Garde, E. M. W., Hardeman, H., Heijligenberg, R., Meijvis, S. C. A., Remmelts, H. H. F., van Velzen-Blad, H., Voorn, P. G. P., & Ovidius Study Group (2017). YKL-40, CCL18 and SP-D predict mortality in patients hospitalized with community-acquired pneumonia. Respirology, 22(3), 542-550. [DOI] [Repository]
Rettig, T. C. D., Verwijmeren, L., Noordzij, P. G., van de Garde, E. M. W., & Boerma, D. (2017). Biomarkers Capable to Early Predict Postoperative Complications: The Grail. Annals of Surgery, 266(6), e92. [DOI]
Rettig, T. C. D., Vermeulen, E., Dijkstra, I. M., van Klei, W. A., Van De Garde, E. M. W., Peelen, L. M., & Noordzij, P. G. (2017). Intraoperative hypotension and change in estimated glomerular filtration rate after major abdominal surgery. European Journal of Anaesthesiology, 34(4), 243-246. [DOI] [Repository]
Vestjens, S. M. T., Wagenvoort, G. H. J., Grutters, J. C., Meek, B., Aldenkamp, A. F., Vlaminckx, B. J. M., Bos, W. J. W., Rijkers, G. T., & van de Garde, E. M. W. (2017). Changes in pathogens and pneumococcal serotypes causing community-acquired pneumonia in The Netherlands. Vaccine, 35(33), 4112-4118. [DOI] [Repository]
Rettig, T. C. D., Peelen, L. M., Geuzebroek, G. S. C., van Klei, W. A., Boer, C., van der Veer, J. W., Hofland, J., van de Garde, E. M. W., & Noordzij, P. G. (2017). Impact of Intraoperative Hypotension During Cardiopulmonary Bypass on Acute Kidney Injury After Coronary Artery Bypass Grafting. Journal of Cardiothoracic and Vascular Anesthesia, 31(2), 522-528. [DOI] [Repository]
Vestjens, S. M. T., Spoorenberg, S. M. C., Rijkers, G. T., Grutters, J. C., ten Berg, J. M., Noordzij, P. G., Van de Garde, E. M. W., Bos, W. J. W., Biesma, D. H., Endeman, H., Hardeman, H., Heijligenberg, R., Meijvis, S. C. A., Remmelts, H. H. F., van Velzen-Blad, H., Voorn, P. G. P., & the Ovidius Study Group (2017). High-sensitivity cardiac troponin T predicts mortality after hospitalization for community-acquired pneumonia. Respirology, 22(5), 1000-1006. [DOI] [Repository]
van Werkhoven, C. H., van de Garde, E. M. W., Oosterheert, J. J., Postma, D. F., & Bonten, M. J. M. (2017). Atypical coverage in community-acquired pneumonia after outpatient beta-lactam monotherapy. Respiratory Medicine, 129, 145-151. [DOI] [Repository]
Koster, E. S., Schmidt, A., Philbert, D., van de Garde, E. M. W., & Bouvy, M. L. (2017). Health literacy of patients admitted for elective surgery. Journal of Public Health , 25(2), 181-186. [DOI] [Repository]
Vakpublicaties
Koster, E. S., Schmidt, A., Philbert, D., van de Garde, E. M. W., & Bouvy, M. L. (2017). Beperkte gezondheidsvaardigheden vormen risico bij ziekenhuisopname: Ruim helft patiënten heeft moeite met complexe gezondheidsbeslissingen. Pharmaceutisch Weekblad, 152(4), 18-19. https://www.pw.nl/achtergrond/2017/beperkte-gezondheidsvaardigheden-vormen-risico-bij-ziekenhuisopname [Repository]
2016
Wetenschappelijke publicaties
van der Aa, M. P., Elst, M. A. J., van de Garde, E. M. W., van Mil, E. G. A. H., Knibbe, C. A. J., & van der Vorst, M. M. J. (2016). Long-term treatment with metformin in obese, insulin-resistant adolescents: results of a randomized double-blinded placebo-controlled trial. Nutrition & diabetes, 6(8), Article e228. [DOI] [Repository]
Vlot, E. A., Meents, N., van de Garde, E. M. W., Hackeng, C. M., & Noordzij, P. G. (2016). Early Point-of-Care Platelet Function Testing Using Multiple Electrode Aggregometry in Patients Undergoing Cardiac Surgery. Journal of Cardiothoracic and Vascular Anesthesia, 30(6), e56-e58. [DOI] [Repository]
van der Aa, M. P., Hoving, V., van de Garde, E. M. W., de Boer, A., Knibbe, C. A. J., & van der Vorst, M. M. J. (2016). The Effect of Eighteen-Month Metformin Treatment in Obese Adolescents: Comparison of Results Obtained in Daily Practice with Results from a Clinical Trial. Journal of Obesity, 2016, Article 7852648. [DOI] [Repository]
Rettig, T. C. D., Verwijmeren, L., Dijkstra, I. M., Boerma, D., Van De Garde, E. M. W., & Noordzij, P. G. (2016). Postoperative interleukin-6 level and early detection of complications after elective major abdominal surgery. Annals of Surgery, 263(6), 1207-1212. [DOI] [Repository]
de Jong, E., van Oers, J. A., Beishuizen, A., Vos, P., Vermeijden, W. J., Haas, L. E., Loef, B. G., Dormans, T., van Melsen, G. C., Kluiters, Y. C., Kemperman, H., van den Elsen, M. J., Schouten, J. A., Streefkerk, J. O., Krabbe, H. G., Kieft, H., Kluge, G. H., van Dam, V. C., van Pelt, J., ... de Lange, D. W. (2016). Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: A randomised, controlled, open-label trial. The Lancet Infectious Diseases, 16(7), 819-827. [DOI] [Repository]
Peters, B. J. M., Janssen, V. E. M. T., Schramel, F. M., & van de Garde, E. M. W. (2016). Quantitative and qualitative assessment of real world data comparative effectiveness research of systemic therapies in lung oncology: A systematic review. Cancer Epidemiology, 44, 5-15. [DOI] [Repository]
Raeven, V. M., Spoorenberg, S. M. C., Boersma, W. G., van de Garde, E. M. W., Cannegieter, S. C., Voorn, G. P. P., Bos, W. J. W., van Steenbergen, J. E., & Alkmaar study group (2016). Atypical aetiology in patients hospitalised with community-acquired pneumonia is associated with age, gender and season; a data-analysis on four Dutch cohorts. BMC Infectious Diseases [E], 16(1), Article 299. [DOI] [Repository]
Noordzij, P. G., Rettig, T. C. D., van de Garde, E. M. W., & van Dongen, E. P. A. (2016). Letter in response to 'Testing the limits: high-sensitivity cardiac troponin in the prediction of non-cardiac complications after major abdominal surgery'. British Journal of Anaesthesia, 116(2), 305-306. [DOI] [Repository]
Vis, R., Malviya, G., Signore, A., Grutters, J. C., Meek, B., van de Garde, E. M. W., & Keijsers, R. G. M. (2016). 99mTc-anti-TNF-α antibody for the imaging of disease activity in pulmonary sarcoidosis. European Respiratory Journal, 47, 1198-1207. [DOI] [Repository]
Banser, A., Naafs, J. C., Hoorweg-Nijman, J. J., van de Garde, E. M., & van der Vorst, M. M. (2016). Advanced glycation end products, measured in skin, vs. HbA1c in children with type 1 diabetes mellitus. Pediatric Diabetes, 17(6), Article 426-432. [DOI] [Repository]
de Hoogd, S., Ahlers, S. J. G. M., van Dongen, E. P. A., van de Garde, E. M. W., Hamilton-ter Brake, A. T., Dahan, A., Tibboel, D., & Knibbe, C. A. J. (2016). Is Intraoperative Remifentanil Associated With Acute or Chronic Postoperative Pain After Prolonged Surgery? An Update of the Literature. Clinical Journal of Pain, 32(8), 726-735. [DOI]
2015
Wetenschappelijke publicaties
Van De Garde, E. M. W., Natsch, S., Prins, J. M., & Van Der Linden, P. D. (2015). Antibiotic prescribing on admission to patients with pneumonia and prior outpatient antibiotic treatment: A cohort study on clinical outcome. BMJ Open, 5(2), Article e006892. [DOI] [Repository]
Rettig, T. C. D., Rigter, S., Nijenhuis, V. J., Van Kuijk, J. P., Ten Berg, J. M., Heijmen, R. H., Van De Garde, E. M. W., & Noordzij, P. G. (2015). The systemic inflammatory response syndrome predicts short-term outcome after transapical transcatheter aortic valve implantation. Journal of Cardiothoracic Vascular Anesthesia, 29(2), 283-287. [DOI] [Repository]
Vestjens, S. M. T., Spoorenberg, S. M. C., Rijkers, G. T., Grutters, J. C., Van De Garde, E. M. W., Meijvis, S. C. A., & Bos, W. J. W. (2015). Antipyretic effect of dexamethasone in community-acquired pneumonia. European Respiratory Journal, 46(2), 570-573. [DOI] [Repository]
Noordzij, P. G., van Geffen, O., Dijkstra, I. M., Boerma, D., Meinders, A. J., Rettig, T. C. D., Eefting, F. D., van Loon, D., van de Garde, E. M. W., & van Dongen, E. P. A. (2015). High-sensitive cardiac troponin T measurements in prediction of non-cardiac complications after major abdominal surgery. British Journal of Anaesthesia, 114(6), 909-918. [DOI] [Repository]
Vis, R., Lavalaye, J., & van de Garde, E. M. W. (2015). GMP-compliant <sup>68</sup>Ga radiolabelling in a conventional small-scale radiopharmacy: a feasible approach for routine clinical use. EJNMMI research [E], 5(1), 1-7. [DOI] [Repository]
2014
Wetenschappelijke publicaties
Spoorenberg, S. M. C., Deneer, V. H. M., Grutters, J. C., Pulles, A. E., Voorn, G. P., Rijkers, G. T., Bos, W. J. W., & Van De Garde, E. M. W. (2014). Pharmacokinetics of oral vs. intravenous dexamethasone in patients hospitalized with community-acquired pneumonia. British Journal of Clinical Pharmacology, 78(1), 78-83. [DOI]
de Groot, M. C. H., Klungel, O. H., Leufkens, H. G. M., van Dijk, L., Grobbee, D. E., & van de Garde, E. M. W. (2014). Sources of heterogeneity in case–control studies on associations between statins, ACE-inhibitors, and proton pump inhibitors and risk of pneumonia. European Journal of Epidemiology, 29(10), 767-775. [DOI]
Hartholt, N. L., Rettig, T. C. D., Schijffelen, M., Morshuis, W. J., van de Garde, E. M. W., & Noordzij, P. G. (2014). Preoperative statin therapy and infectious complications in cardiac surgery. Netherlands Heart Journal, 22(11), 503-9. [DOI] [Repository]
Spoorenberg, S. M. C., Deneer, V. H. M., Grutters, J. C., Pulles, A. E., Voorn, G. P., Rijkers, G. T., Bos, J. W. J., & van de Garde, E. M. W. (2014). Pharmacokinetics of oral vs. intravenous dexamethasone in patients hospitalized with community-aquired pneumonia. British Journal of Clinical Pharmacology, 78(1), 78-83.
Spoorenberg, S. M. C., Bos, W. J., Heijligenberg, R., Voorn, G. P., Grutters, J. C., Rijkers, G. T., & van de Garde, E. M. W. (2014). Microbial aetiology, outcomes, and costs of hospitalisation for community-aquired pneumonia; an observational analysis. BMC Infectious Diseases [E], 14, 335.
2013
Wetenschappelijke publicaties
Remmelts, H. H. F., Spoorenberg, S. M. C., Oosterheert, J. J., Bos, W. J. W., De Groot, M. C. H., & Van De Garde, E. M. W. (2013). The role of vitamin D supplementation in the risk of developing pneumonia: Three independent case-control studies. Thorax, 68(11), 990-996. [DOI]
Peters, B. J. M., Capelle, M. A., Arvinte, T., & van de Garde, E. M. W. (2013). Validation of an automated method for compounding monoclonal antibody patient doses: case studies of Avastin (bevacizumab), Remicade (inlfiximab) and Herceptin (trastuzumab). mAbs, 5(1), 162-170.
Overige resultaten
De Groot, M. C. H., Klungel, O. H., Leufkens, H. G. M., Van Dijk, L., Grobbee, D. E., & Van De Garde, E. M. W. (2013). Multiple database approach for study of associations between frequently used drugs and community-acquired pneumonia. Pharmacoepidemiology and Drug Safety, 22(s1), 289. Article 584. [DOI]
2012
Wetenschappelijke publicaties
Gulik, L., Ahlers, S. J., van de Garde, E. M. W., Bruins, P., van Boven, W. J., Tibboel, D., van Dongen, E. P. A., & Knibbe, C. A. J. (2012). Remifentanil during cardiac surgery is associated with chronic thoracic pain 1 yr after sternotomy. Br J Anaesth, 109(4), 616-22.
Meijvis, S. C. A., van de Garde, E. M. W., Rijkers, G. T., & Bos, W. J. W. (2012). Treatment with anti-inflammatory drugs in community-acquired pneumonia. Journal of Internal Medicine, 272, 25-35.
Ahlers, S. J., Gulik, L., van Dongen, E. P. A., Bruins, P., van de Garde, E. M. W., van Boven, W. J., Tibboel, D., & Knibbe, C. A. J. (2012). Efficacy of an intravenous bolus of morphine 2.5 versus morphine 7.5 mg for procedural pain relief in postoperative cardiothoracic patients in the intensive care unit: a randomised double-blind controlled trial. Anaesth Intensive Care, 40(3), 417-26. http://cat.inist.fr/?aModele=afficheN&cpsidt=25924041
Remmelts, H. H. F., van de Garde, E. M. W., Meijvis, S. C. A., Peelen, E., Damoiseaux, J., Grutters, J. C., Biesma, D. H., Bos, W. J. W., & Rijkers, G. T. (2012). Addition of vitamin D status to prognostic scores improves the prediction of outcome in community-acquired pneumonia. Clinical Infectious Diseases, 55(11), 1488-1494. http://www.ncbi.nlm.nih.gov/pubmed/22942205
2011
Wetenschappelijke publicaties
van den Hoek, H. L., Bos, W. J. W., de Boer, A., & van de Garde, E. M. W. (2011). Statins and prevention of infections: systematic review and meta-analysis of data from large randomised placebo controlled trials. BMJ - Clinical research, 343, d7281.
Meijvis, S. C. A., Cornips, M. C., Endeman, H., Ruven, H. J. T., Danser, A. H. J., Biesma, D. H., Leufkens, H. G. M., Bos, W. J., & van de Garde, E. M. W. (2011). Prognostic value of serum angiotensin-converting enzyme activity for outcome of community-acquired pneumonia. Clinical Chemistry and Laboratory Medicine, 49(9), 1525-1532.
Meijvis, S. C. A., Cornips, M. C., Voorn, G. P., Souverein, P. C., Endeman, H., Biesma, D. H., Leufkens, H. G. M., & van de Garde, E. M. W. (2011). Microbial evaluation of proton-pump inhibitors and the risk of pneumonia. European Respiratory Journal, 38(5), 1165-1172.
van Kralingen, S., Taks, M., Diepstraten, J., van de Garde, E. M., van Dongen, E. P., Wiezer, M. J., van Ramshorst, B., Vlaminckx, B., Deneer, V. H., & Knibbe, C. A. (2011). Pharmacokinetics and protein binding of cefazolin in morbidly obese patients. European Journal of Clinical Pharmacology, 67(10), 985-92. [DOI]
Meijvis, S. C. A., Hardeman, H. H., Remmelts, H. H. F., Heijligenberg, R., Rijkers, G. T., van Velzen-Blad, H., Voorn, G. P., van de Garde, E. M. W., Endeman, H., Grutters, J. C., Bos, W. J., & Biesma, D. H. (2011). Dexamethasone and length of hospital stay in patients with community-acquired pneumonia: a randomised, double-blind, placebo-controlled trial. The Lancet, 377(9782), 2023-2030. http://www.ncbi.nlm.nih.gov/pubmed/21636122
van Kralingen, S., van de Garde, E. M. W., Knibbe, C. A. J., Diepstraten, J., Wiezer, M. J., van Ramshorst, B., & van Dongen, E. P. A. (2011). Comparative evaluation of atracurium dosed on ideal body weight vs. total body weight in morbidly obese patients. British Journal of Clinical Pharmacology, 71(1), 34-40. [DOI]
van Kralingen, S., van de Garde, E. M. W., van Dongen, E. P. A., Diepstraten, J., Deneer, V. H. M., van Ramshorst, B., & Knibbe, C. A. J. (2011). Maintenance of anesthesia in morbidly obese patients using propofol with continuous BIS-monitoring: a comparison of propofol-remifentanil and propofol-epidural anesthesia. Acta Anaesthesiol Belg, 62(2), 73-82.
Keijsers, R. G. M., Verzijlbergen, F. J., van den Bosch, J. M. M., Zanen, P., van de Garde, E. M. W., Oyen, W. J., & Grutters, J. C. (2011). 18F-FDG PET as a predictor of pulmonary function in sarcoidosis. Sarcoidosis, Vasculitis, and Diffuse Lung Diseases, 28(2), 123-129.
2010
Wetenschappelijke publicaties
van Kralingen, S., Diepstraten, J., van de Garde, E. M. W., van der Lely, A. J., van Dongen, E. P. A., van Ramshorst, B., & Knibbe, C. A. J. (2010). Comparative evaluation of propofol 350 and 200 mg for induction of anaesthesia in morbidly obese patients: a randomized double-blind pilot study. Eur J Anaesthesiol, 27(6), 572-4.
2009
Wetenschappelijke publicaties
Lavalaye, J., Grutters, J. C., van de Garde, E. M. W., van Buul, M. M. C., van den Bosch, J. M. M., Windhorst, A. D., & Verzijlbergen, F. J. (2009). Imaging of fibrogenesis in patients with idiopathic pulmonary fibrosis with cis-4-[(18)F]-Fluoro-L: -proline PET. Molecular Imaging and Biology, 11(2), 123-7.
Vakpublicaties
Boom, F., van de Garde, E. M. W., & Vries, P. A. (2009). Sterilisatiemethoden. In Y. Bouwman-Boer, P. Le Brun, C. Oussoren, & H. Woerdenbach (Eds.), Recepteerkunde Bohn Stafleu van Loghum.
2008
Wetenschappelijke publicaties
Van De Garde, E. M. W., Endeman, H., Van Hemert, R. N., Voorn, G. P., Deneer, V. H. M., Leufkens, H. G. M., Van Den Bosch, J. M. M., & Biesma, D. H. (2008). Prior outpatient antibiotic use as predictor for microbial aetiology of community-acquired pneumonia: Hospital-based study. European Journal of Clinical Pharmacology, 64(4), 405-410. [DOI] [Repository]
van de Garde, E. M. W., Endeman, H., Deneer, V. H. M., Biesma, D. H., A Sayed-Tabatabaei, F., Ruven, H. J. T., Leufkens, H. G. M., & van den Bosch, J. M. M. (2008). Angiotensin-Converting Enzyme Insertion/Deletion Polymorphism and Risk and Outcome of Pneumonia. Chest, 133, 220-225. [Repository]
Vakpublicaties
van de Garde, E. M. W., Endeman, H., van Hemert, R. N., Voorn, G. P., Deneer, V. H. M., Leufkens, H. G. M., van den Bosch, J. M. M., & Biesma, D. H. (2008). Antibioticagebruik voor ziekenhuisopname voorspelt microbiologische etiologie van pneumonie. Pharmaceutisch Weekblad, 20, 109-111.
van de Garde, E. M. W. (2008). Statines ter preventie van pneunomie. Huisarts en Wetenschap, 51, 195-197.
Overige resultaten
van de Garde, E. M. W., Deneer, V. H. M., Souverein, P. C., van den Bosch, J. M. M., & Leufkens, H. G. M. (2008). Validation of Community-Acquired Pneumonia: High Postitive Predictive Value for ICD-9 Codes. S248. Abstract from 24th International Conference on Pharmacoepidemiology & Therapeutic Risk Management.
2007
Wetenschappelijke publicaties
Van De Garde, E. M. W., Endeman, H., Deneer, V. H. M., Biesma, D. H., Ruven, H. J. T., Van Velzen-Blad, H., Leufkens, H. G. M., & Van Den Bosch, J. M. M. (2007). Angiotensin-converting enzyme (ACE) I/D corrected serum ACE activity and severity assessment of community-acquired pneumonia. Clinical Chemistry and Laboratory Medicine, 45(10), 1326-1331. [DOI]
van de Garde, E. M. W. (2007). Drug effects on the risk and prognosis of community-acquired pneumonia. [Doctoral thesis 1 (Research UU / Graduation UU), Utrecht University].
van de Garde, E. M. W., Souverein, P. C., Hak, E., Deneer, V. H. M., van den Bosch, J. M. M., & Leufkens, H. G. M. (2007). Angiotensin-converting enzyme inhibitor use and protection against pneumonia in patients with diabetes. Journal of Hypertension, 25(1), 235-239. [DOI] [Repository]
van de Garde, E. M. W., Oosterheert, J. J., Bonten, M. J. M., Kaplan, R. C., & Leufkens, H. G. M. (2007). International classification of diseases codes showed modest sensitivity for detecting community-aquired pneumonia. Journal of Clinical Epidemiology, 60(8), 834-838. [Repository]
van de Garde, E. M. W., Endeman, H., Deneer, V. H. M., Biesma, D. H., Ruven, H. J. T., van Velzen-Blad, H., Leufkens, H. G. M., & van den Bosch, J. M. M. (2007). Angiotensin-converting enzyme (ACE) I/D corected serum ACE activity and severity assessment of community-acquired pneumonia. Clinical Chemistry and Laboratory Medicine, 45(10), 1326-1331. [Repository]
Overige resultaten
van de Garde, E. M. W., Endeman, H., Deneer, V. H. M., Biesma, D. H., & A Sayed-Tabatabaei, F. (2007). Angiotensin-Converting Enzyme Insertion/Deletion Polymorphism and Risk and Outcome of Pneumonia. S171. Abstract from 23rd International Conference on Pharmacoepidemiology & Therapeutic Risk Management.
2006
Wetenschappelijke publicaties
van de Garde, E. M. W., Souverein, P. C., van den Bosch, J. M. M., Deneer, V. H. M., & Leufkens, H. G. M. (2006). Angiotensin-converting enzyme inhibitor use and pneumonia risk in a general population. European Respiratory Journal, 27(6), 1217-1222. [DOI]
van de Garde, E. M. W., Hak, E., Souverein, P. C., Hoes, A. W., van den Bosch, J. M. M., & Leufkens, H. G. M. (2006). Statin treatment and reduced risk of pneumonia in patients with diabetes. Thorax, 61(11), 957-961. [Repository]
van de Garde, E. M. W., Souverein, P. C., van den Bosch, J. M. M., Deneer, V. H. M., Goettsch, W. G., & Leufkens, H. G. M. (2006). Prior outpatient antibacterial therapy as prognostic factor for mortality in hospitalized pneumonia patients. Respiratory Medicine, 100(8), 1342-1348. [DOI]
van de Garde, E. M. W., Bras, L. J., Heijmen, R. H., Knibbe, C. A. J., van Dongen, E. P. A., Wiltink, E. H. H., & Biesma, D. H. (2006). Low-Dose Recombinant Factor VIIa in the Management of Uncontrolled Postoperative Hemorrhage in Cardiac Surgery Patients. Journal of Cardiothoracic Vascular Anesthesia, 20(4), 573-575. [Repository]
Overige resultaten
van de Garde, E. M. W., Hak, E., Souverein, P. C., Hoes, A. W., van den Bosch, J. M. M., & Leufkens, H. G. M. (2006). Statin Therapy and Reduced Risk of Pneumonia in Elderly Patients with Diabetes. S47. Abstract from Unknown event, Asilomar, USA.
2005
Vakpublicaties
Van De Garde, E. M. W., & Tjoeng, M. M. (2005). Status klinische farmacie als onderdeel electronisch patientendossier. Pharmaceutisch Weekblad, 140(46), 1461-1464.
Overige resultaten
van de Garde, E. M. W., van den Bosch, J. M. M., Deneer, V. H. M., Souverein, P. C., & Leufkens, H. G. M. (2005). Use of ACE-Inhibitors and Risk of Community-Acquired Pneumonia. S135. Abstract from Unknown event, Asilomar, USA.
2004
Vakpublicaties
Van De Garde, E. M. W. (2004). Geneesmiddel als diagnosticus. Pharmaceutisch Weekblad, 139(34), 1084.